DrugId:  1
1. Name:  Vilaprisan
2. Groups:  Investigational
3. Description:  Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.
4. Indication:  Not Available
DrugId:  2
1. Name:  Tazemetostat
2. Groups:  Investigational
3. Description:  Tazemetostat has been used in trials studying the treatment of Rhabdoid Tumors, Synovial Sarcoma, Epithelioid sarcoma, INI1-negative Tumors, and Renal Medullary Carcinoma, among others.
4. Indication:  Not Available
